m.coelho
TL2 Moderator · Łódź
Contributes reviews on supplier material. Based in Łódź.
Joined 18 August 2025 · last posted 8d
85Posts here
1Topics
1Solutions
2kLikes received
1.2kLikes given
22Badges
260Days visited
4.8kPosts read
Recent activity
Full stream-
Priming a pen and whether the primed volume is wasted Replied, post #14 · Devices › Pens & autoinjectors · 20 Jul 2026 · 2 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #62 · Start Here › Welcome · 20 Jul 2026 · 1 like post #61 answers the question as asked. The question underneath it is different. Welcome. The orientation materials are pinned at the top of this category and they take…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #81 · Wellbeing › Sleep · 10 Jul 2026 · 15 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Submitting a sample: the process end to end Replied, post #66 · Sourcing › Independent verification · 8 Jul 2026 · 27 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #3 · Compounds › Repair & healing peptides · 7 Jul 2026 · 1 like For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #34 · Practice › Dosing & titration · 3 Jul 2026 · 31 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #8 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #89 · Start Here › How to Ask · 2 Jul 2026 · 1 like post #88 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #52 · Evidence › Journal club · 28 Jun 2026 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Athletes in weight-category sports: a different risk calculus Replied, post #3 · Clinical › Special populations · 25 Jun 2026 · 16 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #25 · Analytics › Home & field testing · 24 Jun 2026 · 0 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #12 · Compounds › Retatrutide · 22 Jun 2026 · 8 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…